skip to main content

    Updated Visitor Guidelines

 

MENU

 

A Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab and the Combination Nivolumab Plus Ipilimumab in Patients With Advanced Liver Cancer

This trial is no longer accepting participants. To get assistance / information to find a clinical trial that is right for you, please call Cancer AnswerLine at 800-865-1125.